SEZ TECHNOPOLIS MOSCOW LAUNCHES PRODUCTION OF DRUGS FROM THE VITAL MEDICINES LIST
A tenant of the special economic zone Technopolis Moscow company AMEDART since the end of August has launched the production of 17 types of drugs from the list of vital and essential medicines, as informed by Vladimir Efimov, Deputy Mayor of Moscow for economic policy and property and land relations.
The list of drugs to be produced by the resident of the special economic zone includes HIV drugs, renal failure drugs, as well as anticoagulants, chelators and immunosuppressants.
“The total investment in the production will amount to over 700 million Rubles. In 2021, the first batches of drugs will be released in the amount of 100 thousand packages. Once the production reaches full capacity by 2024, the enterprise will produce 1.5 million packages per year and supply them to medical institutions in Moscow and other regions of the country”, Vice-Mayor announced.
In the next four years, the company plans to start production of 29 more pharmaceutical products, informed Alexander Prokhorov, Head of the Department of investment and industrial policy of Moscow.
“Next year, the company will launch the production of three types of drugs for the treatment of diabetes mellitus, and by 2024 - another 26 drugs against malignancy. The products planned for production are also included in the list of vital and essential medicines, which will allow selling the drugs of the capital manufacturer at affordable prices and significantly reduce dependence on imported analogues”, pointed Alexander Prokhorov.
The company AMEDART has been a resident of SEZ Technopolis Moscow since mid-2019, added Gennady Degtev, CEO of SEZ Technopolis Moscow.
“The company's production
occupies almost 6 thousand square meters at the site in Pechatniki. Now the
company employs over 40 employees. Resident status gives the company access to
the main benefits - a zero rate on property and transport, as well as a reduced
income tax. The company will be able to refinance the funds saved on benefits
for new developments and improvement of the material and technical base”, noted
the Head of Technopolis.